Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus.

Gitto M, Filiberti G, Leone PP, Chiarito M, Gurgoglione FL, Tartaglia F, Frazzetto M, Calamita G, Rossi ML, Bernardini V, Reimers B, Regazzoli D, Mangieri A, Gasparini G, Briguori C, Latib A, Stefanini GG, Godino C, Sardella G, Cortese B, Colombo A

Open source

DOI: 10.1186/s12933-026-03110-6
Published: 2026 Mar 4
Container: Cardiovascular diabetology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12933-026-03110-6,
  title = {Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus.},
  author = {Gitto M and Filiberti G and Leone PP and Chiarito M and Gurgoglione FL and Tartaglia F and Frazzetto M and Calamita G and Rossi ML and Bernardini V and Reimers B and Regazzoli D and Mangieri A and Gasparini G and Briguori C and Latib A and Stefanini GG and Godino C and Sardella G and Cortese B and Colombo A},
  year = {2026},
  journal = {Cardiovascular diabetology},
  doi = {10.1186/s12933-026-03110-6},
  url = {https://doi.org/10.1186/s12933-026-03110-6}
}

RIS

TY  - JOUR
TI  - Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus.
AU  - Gitto M
AU  - Filiberti G
AU  - Leone PP
AU  - Chiarito M
AU  - Gurgoglione FL
AU  - Tartaglia F
AU  - Frazzetto M
AU  - Calamita G
AU  - Rossi ML
AU  - Bernardini V
AU  - Reimers B
AU  - Regazzoli D
AU  - Mangieri A
AU  - Gasparini G
AU  - Briguori C
AU  - Latib A
AU  - Stefanini GG
AU  - Godino C
AU  - Sardella G
AU  - Cortese B
AU  - Colombo A
PY  - 2026
JO  - Cardiovascular diabetology
DO  - 10.1186/s12933-026-03110-6
UR  - https://doi.org/10.1186/s12933-026-03110-6
ER  -

APA

M, G., G, F., PP, L., M, C., FL, G., F, T., M, F., G, C., ML, R., V, B., B, R., D, R., A, M., G, G., C, B., A, L., GG, S., C, G., G, S., B, C., & A, C. (2026). Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus.. Cardiovascular diabetology. https://doi.org/10.1186/s12933-026-03110-6

Source records

pubmed · retrieved 2026-09-26T14:32:20.782Z